Latest News

  • All
  • ATAI Life Sciences
  • BetterLife Pharma
  • Braxia Scientific
  • Bright Minds Biosciences
  • Champignon Brands
  • Compass Pathways
  • Core One Labs
  • Cybin Inc
  • Entheon Biomedical
  • Field Trip Health
  • Havn Life
  • MindMed
  • Mindset Pharma
  • Mydecine Innovations Group
  • Numinus Wellness
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • Tryp Therapeutics

Mydecine Files Full Patent Application Covering Multiple Families of Psilocin Analogs

December 6, 2021
Dr. Saeid Babaei Appointed Independent Board Member as Mydecine Moves Closer to NASDAQ Listing in Q1 2022 DENVER, Dec. 06, 2021 (GLOBE NEWSWIRE) — Mydecine ...

Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th

December 2, 2021
December 02, 2021 08:30 ET | Source: Mindset Pharma Inc. TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the ...

Silo Pharma Announces Grant of U.S. Patent For its Novel CNS Homing Peptide

December 2, 2021
U.S. Patent and Trademark Office issued US Patent No. 11,174,287 investigation, detection, treatment or prevention of neuroinflammation December 02, 2021 08:10 ET | Source: Silo Pharma, Inc. ...

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

November 30, 2021
— Hundreds of de novo patentable psychedelic-based compounds created through discovery program — — Company plans to announce lead molecule in first quarter of 2022 — VANCOUVER, ...

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress

November 30, 2021
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that the U.S. Food and Drug ...

Mindset to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th

November 29, 2021
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused ...

Newsletter

Sign up for the latest news and info direct from Psychedelic Europe

Follow us on social media

Facebook Twitter Linkedin Youtube

Privacy Policy ♦ Terms and Conditions 

All rights reserved – Psychedelic Europe 2021

Designed and built by Stellium